2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Neuromuscular Blockade Reversal Agent: new trials by email Literature Review of Neuromuscular Blockade Reversal Agent trials Research Report on Neuromuscular Blockade Reversal Agent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Neostigmine and Sugammadex on the Optic Nerve Sheath Diameter Sugammadex 2 mg/kg, Neostigmine + Atropine - Neuromuscular Blockade Reversal Agent | Phase 4 | Completed | Cukurova University | 86 | 2026-06-25 | 2026-10-21 |
| Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine Sugammadex, Neostigmine - Neuromuscular Blockade Reversal Agent, Sugammadex | Phase 4 | Completed | Seoul National University Bundang Hospital | 77 | 2020-02-24 | 2020-12-24 |
Neostigmine (2) · Sugammadex (2) · Atropine (1)
Cukurova University (1) · Seoul National University Bundang Hospital (1)
South Korea (1) · Turkey (Türkiye) (1)
Ersel Gulec, MD (1) · Jiwon Han, Ms (1)